secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001104659-21-093550
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. prices $40M IPO; 4M units at $10 each
---------------------------------------------------------------

- IPO of 4,000,000 units at $10.00/unit, gross proceeds of $40 million; over-allotment option of 600,000 units available.
- Private placement of 295,000 shares to founders at $10/share, raising $2.95 million concurrent with IPO closing.
- Net proceeds of $40.8 million ($40M IPO + $0.8M private placement) placed in trust account for business combination.
- Board classified: Weston Twigg (Class I, 2022), Tao Jiang & James Long (Class II, 2023), Jianwei Li & Weiguang Yang (Class III, 2024).
- Units listed on Nasdaq under UPTDU starting July 15; common stock (UPTD) and warrants (UPTDW) will trade separately later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000110465921093550/0001104659-21-093550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000110465921093550/tm2122516d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-093550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer